Cytosurge establishes 3D printing spin-off
Glattbrugg ZH/Buchberg SH – Cytosurge originally developed its FluidFM technology for biological research purposes. Since then, the company has further developed the technology for new applications in the area of micro 3D printing. Now, it has established a spin-off to exclusively focus on 3D printing processes.
Greater Zurich has a new unicorn
Zurich – The start-up Numbrs from the Greater Zurich Area has raised a total of 40 million dollars. The fintech is now valued at over 1 billion dollars and can therefore be described as a unicorn.
Peripal wins health insurance company trust
Zurich – Peripal, a medtech startup from the Greater Zurich Area, has developed an at-home dialysis device for patients with chronic kidney disease. It is now receiving reimbursement from three Swiss health insurance companies.
Lucerne University opens Zug-Rotkreuz campus
Rotkreuz ZG – The Lucerne University of Applied Sciences and Arts is opening its new campus in Zug-Rotkreuz on September 14. Located in Switzerland’s tallest wooden building, the campus houses the School of Information Technology and the Institute of Financial Services.
Araris Biotech raises 2.5 million Swiss francs
Zurich – Just six months after it was founded, Araris Biotech has raised over 2.5 million Swiss francs in seed financing. The funds will go towards developing its novel antibody-drug conjugates for the targeted treatment of cancerous tumors.
ANYbotics develops next generation of robots
Zurich – Robot manufacturer ANYbotics has developed a new generation of its four-legged robot. ANYmal C can conduct autonomous inspections in industrial environments.
Nexxiot digitalizes Unilode’s air freight fleet
Zurich/Kloten - Nexxiot is now the official partner of Unilode Aviation Solutions. Together, the two companies want to realize a globally unique project: digitalizing Unilode’s entire ULD fleet.
Researchers develop new cancer treatment
Zurich – Scientists at the University of Zurich have developed a chemical compound that allows drugs to be transported directly to the prostate in order to fight tumors in the gland. For this, they are making use of graphene nanoflakes.
Biotech project receives funding from Innosuisse
Zurich - The biotech start-up Cutiss AG is working on a machine to produce personalized skin grafts in automated fashion. The joint-project with CSEM has now received financial support to the tune of over 800,000 Swiss francs from Innosuisse.
Meet with an expansion expert
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line.